scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Stephen Kent | Q39274630 |
Keith W. Kelley | Q47809179 | ||
Robert Dantzer | Q3434896 | ||
P2093 | author name string | Bluthé RM | |
R. M. Bluthé | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 24-28 | |
P577 | publication date | 1992-01-01 | |
P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
P1476 | title | Sickness behavior as a new target for drug development | |
P478 | volume | 13 |
Q34631232 | A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase |
Q36541051 | A dialogue between the immune system and brain, spoken in the language of serotonin |
Q36510158 | A neuromodulatory role of interleukin-1beta in the hippocampus |
Q33863128 | A new concept in neurodegeneration: TNFalpha is a silencer of survival signals |
Q37395509 | A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder |
Q37725843 | A psychoneuroimmunological review on cytokines involved in antidepressant treatment response |
Q37551559 | A qualitative investigation of eating difficulties in adolescents with chronic fatigue syndrome/myalgic encephalomyelitis. |
Q33587452 | A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers |
Q43596371 | Action of glucocorticoids to antagonise cisplatin-induced acute and delayed emesis in the ferret. |
Q33553907 | Activation of lung toll-like receptors does not exacerbate sickness responses to lipopolysaccharide in mice |
Q38836831 | Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology. |
Q45163794 | Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats |
Q48291231 | Acute hypoxia activates the neuroimmune system, which diabetes exacerbates. |
Q31883849 | Acute interferon-alpha administration modulates sucrose consumption in the rat. |
Q24796836 | Age-dependent changes in 24-hour rhythms of catecholamine content and turnover in hypothalamus, corpus striatum and pituitary gland of rats injected with Freund's adjuvant |
Q73814091 | Age-dependent effect of Freund's adjuvant on 24-hour rhythms in plasma prolactin, growth hormone, thyrotropin, insulin, follicle-stimulating hormone, luteinizing hormone and testosterone in rats |
Q40589118 | Alcohol consumption attenuates febrile responses to lipopolysaccharide and interleukin-1 beta in male rats |
Q28302013 | Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders |
Q44630690 | Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B. |
Q37323491 | An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences |
Q34350258 | Anterior cingulate activation and error processing during interferon-alpha treatment |
Q44000222 | Antidepressant reversal of interferon-alpha-induced anhedonia |
Q87474610 | Antidepressant treatment of cytokine-induced mood disorders |
Q38894095 | Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation? |
Q28387292 | Association of Baseline Sleep Quality With Trajectories of Depressive Symptoms in Patients Undergoing Interferon Treatment |
Q40834414 | Augmented interleukin-1beta-induced depression of locomotor activity in cholestatic rats |
Q48175206 | Behavior of adult and aged mice before and after central injection of interleukin-1beta |
Q44549468 | Behavioral and endocrine effects of endotoxin in wild-type mice and mice deficient in interleukin 1: sickness behavior or adaptive response? |
Q35031612 | Behavioral and motivational effects of immune-system activation |
Q33855426 | Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects |
Q35114037 | Behavioral patterns associated with chemotherapy-induced emesis: a potential signature for nausea in musk shrews. |
Q48344334 | Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition |
Q38334207 | Blockade of the leptin-sensitive pathway markedly reduces alcohol consumption in mice |
Q71789032 | Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study |
Q40531139 | Body temperature, behavior, and plasma cortisol changes induced by chronic infusion of Staphylococcus aureus in goats |
Q32041354 | Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. |
Q73816112 | Brain interleukin-1beta and tumor necrosis factor-alpha are involved in lipopolysaccharide-induced delayed rectal allodynia in awake rats |
Q47966785 | Brain neurotransmission during peripheral inflammation |
Q64933067 | Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. |
Q37310546 | Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets |
Q44511445 | C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence |
Q48759512 | C3H/HeJ mice are refractory to lipopolysaccharide in the brain |
Q40509061 | Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation. |
Q40653313 | Central amygdala Fos expression during hypotensive or febrile, nonhypotensive endotoxemia in conscious rats |
Q43943124 | Central infusion of vasopressin in male rats accelerates extinction of conditioned taste avoidance induced by LiCl |
Q37246929 | Central inhibition of interleukin-1beta ameliorates sickness behavior in aged mice. |
Q48249120 | Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. |
Q41590564 | Central interleukin-1 receptors as mediators of sickness. |
Q35651109 | Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit |
Q74271987 | Characterization of lipopolysaccharide-induced emesis in conscious piglets: effects of cervical vagotomy, cyclooxygenase inhibitors and a 5-HT(3) receptor antagonist |
Q44567469 | Chronic interferon-alpha potentiates latent inhibition in rats. |
Q37099861 | Chronic occupational exposures can influence the rate of PTSD and depressive disorders in first responders and military personnel |
Q37475438 | Chronobiology and the horse: recent revelations and future directions. |
Q40554156 | Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge |
Q48273581 | Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus |
Q40604359 | Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. |
Q51853484 | Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model. |
Q35106010 | Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial |
Q48721954 | Conditioned fear to context is associated with increased Fos expression in the caudal ventrolateral region of the midbrain periaqueductal gray. |
Q90408067 | Conditioned taste aversions |
Q40672325 | Corticosterone controls interleukin-1 beta expression and sickness behavior in the rat. |
Q37440427 | Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings |
Q33964676 | Cytokine-induced sickness behavior. |
Q40473376 | Cytokine-to-brain communication: A review & analysis of alternative mechanisms |
Q34052859 | Cytokines and advanced cancer |
Q47953009 | Cytokines and blood-brain barrier permeability |
Q35032954 | Cytokines and depression |
Q37884614 | Cytokines and depression: findings, issues, and treatment implications |
Q43760709 | Cytokines and neuroendocrine dysregulation in obstructive cholestasis: pathophysiological implications |
Q35077109 | Cytokines and sickness behavior: implications for cancer care and control |
Q60777367 | Cytokines et cerveau |
Q60777363 | Defect in Interleukin-1β Secretion Prevents Sickness Behavior in C3H/HeJ Mice |
Q39417482 | Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression |
Q35189654 | Depression in cancer: new developments regarding diagnosis and treatment |
Q35236177 | Depression in late life: psychiatric-medical comorbidity |
Q34453593 | Depression, cytokines, and pancreatic cancer |
Q41705538 | Depression, stress and immunological activation: the role of cytokines in depressive disorders |
Q46896366 | Developmental exposure to corticosterone: behavioral changes and differential effects on leukemia inhibitory factor (LIF) and corticotropin-releasing hormone (CRH) gene expression in the mouse |
Q34053569 | Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: the Multi-Ethnic Study of Atherosclerosis |
Q48576305 | Different receptor mechanisms mediate the effects of endotoxin and interleukin-1 on female sexual behavior |
Q33971359 | Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1 |
Q48572246 | Differential effects of immunologic challenge on self-stimulation from the nucleus accumbens and the substantia nigra |
Q48528729 | Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation |
Q53773295 | Distribution of brain monoamines in left- and right-handed mice injected with bacillus Calmette-Guerin. |
Q33720173 | Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists |
Q33964349 | Dysthymia: a review of pharmacological and behavioral factors |
Q46770389 | Early maternal separation leads to down-regulation of cytokine gene expression |
Q30487006 | Early-life programming of later-life brain and behavior: a critical role for the immune system |
Q47303304 | Effect of Interleukin-1beta on Pituitary-Adrenal Responses and Body Weight in Neonatal Rats: Interaction with Maternal Deprivation |
Q91908784 | Effect of Spray-Dried Plasma Form and Duration of Feeding on Broiler Performance During Natural Necrotic Enteritis Exposure |
Q51351500 | Effect of cervical vagotomy on sympathetic nerve responses to peripheral interleukin-1beta. |
Q49097885 | Effect of local sympathectomy on 24-h changes in mitogenic responses and lymphocyte subset populations in rat submaxillary lymph nodes during the preclinical phase of Freund's adjuvant arthritis. |
Q43689402 | Effect of melatonin on 24h changes in plasma protein levels during the preclinical phase of Freund's adjuvant arthritis in rats |
Q57222283 | Effects of Monoclonal Antibodies to Specific Epitopes of Rat Interleukin‐1 Beta (IL‐Iβ) on IL‐1β‐Induced ACTH, Corticosterone and IL‐6 Responses in Rats |
Q36262535 | Effects of cytokines and infections on brain neurochemistry |
Q35989109 | Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice |
Q36054579 | Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests |
Q41687238 | Effects of low-dose lipopolysaccharide and age on spatial learning in different Morris water maze protocols |
Q35746360 | Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task |
Q40093821 | Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization |
Q42052097 | Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events |
Q28568408 | Elevation in type I interferons inhibits HCN1 and slows cortical neuronal oscillations |
Q57294768 | Endotoxin rapidly desensitizes the gonads to kisspeptin-induced luteinizing hormone release in male Siberian hamsters () |
Q40687142 | Endotoxin-induced appearance of immunoreactive interleukin-1β in ramified microglia in rat brain: A light and electron microscopic study |
Q36514175 | Environmental context differentially affects behavioral, leukocyte, cortisol, and interleukin-6 responses to low doses of endotoxin in the rhesus monkey |
Q36589656 | Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. |
Q48179902 | Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice |
Q83939165 | Expression and localization of p80 interleukin-1 receptor protein in the rat spinal cord |
Q34769039 | Fatigue in cholestatic liver disease--a perplexing symptom |
Q40632315 | Fetal alcohol exposure attenuates interleukin-1beta-induced fever: neuroimmune mechanisms |
Q55001002 | From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. |
Q41910462 | Gene expression biomarkers of response to citalopram treatment in major depressive disorder |
Q34198749 | Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment |
Q47952446 | Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease |
Q37592633 | Histological Architecture Underlying Brain-Immune Cell-Cell Interactions and the Cerebral Response to Systemic Inflammation |
Q40505736 | Hormonal, behavioral, and thermoregulatory responses to bacterial lipopolysaccharide in captive and free-living white-crowned sparrows (Zonotrichia leucophrys gambelii). |
Q34080545 | Hormones and mating system affect sex and species differences in immune function among vertebrates |
Q41431262 | Hormones, lymphohemopoietic cytokines and the neuroimmune axis. |
Q60440998 | How does stress affect you? An overview of stress, immunity, depression and disease |
Q73128586 | Hyperalgesia induced by low doses of thymulin injections: possible involvement of prostaglandin E2 |
Q41418798 | Hypothalamic Inflammation and Energy Balance Disruptions: Spotlight on Chemokines |
Q48602138 | Immobilization stress increases mRNA levels of interleukin-1 receptor antagonist in various rat brain regions |
Q48368954 | Immune and endocrine regulation of food intake in sick animals |
Q40639271 | Immune stimulation induces Fos expression in brainstem amygdala afferents |
Q36908139 | Immune system inflammation in cocaine dependent individuals: implications for medications development |
Q34769827 | Immune system to brain signaling: neuropsychopharmacological implications. |
Q33746873 | Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain |
Q28553564 | Immune-Challenged Fish Up-Regulate Their Metabolic Scope to Support Locomotion |
Q89963861 | Immune-Endocrine Links to Gregariousness in Wild House Mice |
Q34550430 | Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review |
Q48444800 | Immunological and neuroendocrine modulation of fever in stress. |
Q24683277 | Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes |
Q33679530 | Implications of immune-to-brain communication for sickness and pain |
Q34011838 | In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain |
Q48300504 | Individual variation in hypothalamus-pituitary-adrenal responsiveness of rats to endotoxin and interleukin-1 beta |
Q30439385 | Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect |
Q37688991 | Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications |
Q39098530 | Inflammation and depression: a causal or coincidental link to the pathophysiology? |
Q33910359 | Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer |
Q30476283 | Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness. |
Q34137763 | Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions |
Q38346438 | Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function |
Q44456108 | Interleukin balance and early recovery from anesthesia in elderly surgical patients exposed to beta-adrenergic antagonism |
Q37328706 | Interleukin-1 (IL-1): a central regulator of stress responses. |
Q41529538 | Interleukin-1 activates transcription factor NF kappa B in glial cells |
Q48383630 | Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve |
Q47966865 | Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness |
Q48497348 | Interleukin-1-induced sickness behavior depends on behavioral lateralization in mice |
Q48765700 | Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins. |
Q47623195 | Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice |
Q35061499 | LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1Β levels in adult rat offspring: relevance to autism |
Q73466673 | Lack of evidence for a role of serotonin in interleukin-1-induced hypophagia |
Q35990442 | Leptin: at the crossroads of energy balance and systemic inflammation |
Q37021268 | Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression |
Q48830733 | Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. |
Q44462735 | Lipopolysaccharide induces biochemical alterations in chicks trained on the passive avoidance learning task. |
Q52020017 | Lipopolysaccharide induces memory-processing deficits in day-old chicks. |
Q37713186 | Lipopolysaccharide reduces food passage rate from the crop by a prostaglandin-independent mechanism in chickens. |
Q48399419 | Lipopolysaccharide-induced expression of IP-10 mRNA in rat brain and in cultured rat astrocytes and microglia |
Q44100136 | Long-term consequences of social stress on corticosterone and IL-1beta levels in endotoxin-challenged rats |
Q51999219 | Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. |
Q52005596 | Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments. |
Q36808165 | Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7 |
Q35213470 | Measuring sickness behavior in the context of pancreatic cancer |
Q38215005 | Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling |
Q40647963 | Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat. |
Q41056408 | Metallothionein differentially affects the host response to Listeria infection both with and without an additional stress from cold-restraint |
Q48300514 | Molecular basis of sickness behavior |
Q33732289 | Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis |
Q48001127 | Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue |
Q37056414 | Mouse short- and long-term locomotor activity analyzed by video tracking software |
Q34441102 | Neonatal stress modulates sickness behavior. |
Q34145037 | Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? |
Q40764035 | Neurobiological aspects of the chronic fatigue syndrome |
Q48427552 | Neuroendocrine and immune system interactions in stress and depression |
Q38986568 | Neuroendocrine-immune circuits, phenotypes, and interactions |
Q47851508 | Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa |
Q38226495 | Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process |
Q38015254 | Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics |
Q37432089 | Neuroinflammation and comorbidity of pain and depression |
Q37116106 | Neuroinflammation, neurodegeneration, and depression. |
Q98564963 | Neuronal regulation of immunity: why, how and where? |
Q34203214 | Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling |
Q44394172 | Neuroprotective properties of tianeptine: interactions with cytokines |
Q34081783 | Neuropsychiatric adverse effects of interferon-alpha: recognition and management |
Q31028708 | Neuropsychiatric symptoms in patients with aortic aneurysms |
Q89860282 | New Insights into the Role of Glutathione in the Mechanism of Fever |
Q36956409 | Nicotine administration and withdrawal affect survival in systemic inflammation models |
Q36605328 | PPARγ activation prevents impairments in spatial memory and neurogenesis following transient illness |
Q34306731 | Paradigms for behavioral assessment of viral pathogenesis |
Q35763344 | Pathophysiology of cancer-related fatigue |
Q37667770 | Peripheral tumors alter neuroinflammatory responses to lipopolysaccharide in female rats |
Q34578591 | Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol |
Q44478728 | Physical activity alters the brain Hsp72 and IL-1beta responses to peripheral E. coli challenge |
Q37383933 | Physiology and pathophysiology of prostanoid receptors |
Q58350916 | Placebo: no longer a phantom response |
Q40855688 | Polyunsaturated fatty acids levels and initial presentation of somatic symptoms induced by interferon-alpha therapy in patients with chronic hepatitis C viral infection |
Q45050810 | Possible role of central interleukins on the anorexigenic effect of lipopolysaccharide in chicks |
Q48364063 | Priming enhances endotoxin-induced thermal hyperalgesia and mechanical allodynia in rats |
Q41823445 | Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection |
Q35104455 | Proinflammatory cytokines, sickness behavior, and Alzheimer disease |
Q36240300 | Propentofylline Prevents Sickness Behavior and Depressive-Like Behavior Induced by Lipopolysaccharide in Rats via Neuroinflammatory Pathway |
Q30476333 | Prostaglandin E receptor EP1 controls impulsive behavior under stress. |
Q50940247 | Recommended housing conditions and test procedures can interact to obscure a significant experimental effect. |
Q48558756 | Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene |
Q35189666 | Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment |
Q38290421 | Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression. |
Q36498710 | Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior |
Q47558832 | Repeated lipopolysaccharide exposure modifies immune and sickness behaviour response in an animal model of chronic inflammation |
Q38136672 | Research review: the role of cytokines in depression in adolescents: a systematic review |
Q26998822 | Rethinking inflammation: neural circuits in the regulation of immunity |
Q38843539 | Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders |
Q34311135 | Role of circumventricular organs in pro-inflammatory cytokine-induced activation of the hypothalamic-pituitary-adrenal axis |
Q48774229 | Role of corticosterone in the behavioral effects of central interleukin-1 beta |
Q74587634 | Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monocyte IL-6 production |
Q40437121 | Role of interleukin-1 in stress responses. A putative neurotransmitter |
Q48693890 | Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice |
Q37558881 | Safety, tolerability, and biomarkers of the treatment of mice with aerosolized Toll-like receptor ligands |
Q34579360 | Sex differences in the response to influenza virus infection: modulation by stress |
Q36472381 | Sex-dependent effects of neonatal inflammation on adult inflammatory markers and behavior |
Q54205903 | Short day lengths attenuate the symptoms of infection in Siberian hamsters. |
Q33783903 | Sickness and behaviour in animals: a motivational perspective |
Q43192652 | Sickness-related odor communication signals as determinants of social behavior in rat: a role for inflammatory processes |
Q48227989 | Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients |
Q36945216 | Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. |
Q40580228 | Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge |
Q40556667 | Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain |
Q38661731 | Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression |
Q48897507 | Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder |
Q40646714 | Subdiaphragmatic vagotomy does not prevent fever following intracerebroventricular prostaglandin E2: further evidence for the importance of vagal afferents in immune-to-brain communication |
Q94951099 | Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection |
Q40240331 | Sulforaphane reduces lipopolysaccharide-induced proinflammatory markers in hippocampus and liver but does not improve sickness behavior |
Q45504028 | Symptom burden in cancer survivorship |
Q53256501 | Symptom clusters in cancer patients. |
Q43505103 | Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1beta. |
Q37044561 | Systemic immune activation leads to neuroinflammation and sickness behavior in mice |
Q44539411 | T-cell homeostasis in breast cancer survivors with persistent fatigue |
Q82068670 | TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice |
Q60686591 | TNF-α–Induced Corticosterone Elevation But Not Serum Protein or Corticosteroid Binding Globulin Reduction Is Vagally Mediated |
Q46046814 | Testosterone treatment diminishes sickness behavior in male songbirds |
Q43919489 | The COX inhibitors indomethacin and meloxicam exhibit anti-emetic activity against cisplatin-induced emesis in piglets |
Q102322207 | The Sickness Behavior Inventory-Revised: Sickness behavior and its associations with depression and inflammation in patients with metastatic lung cancer |
Q40622142 | The amount of free corticosterone is increased during lipopolysaccharide-induced fever. |
Q38203302 | The biology of depression in cancer and the relationship between depression and cancer progression |
Q34450830 | The central opioid system in liver disease and its complications |
Q33959742 | The concept of sickness behavior: a brief chronological account of four key discoveries. |
Q35592049 | The inflammasome: pathways linking psychological stress, depression, and systemic illnesses |
Q34904703 | The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression |
Q48352001 | The long term acute phase-like responses that follow acute stressor exposure are blocked by alpha-melanocyte stimulating hormone |
Q33637790 | The olfactory nerve has a role in the body temperature and brain cytokine responses to influenza virus |
Q36762660 | The relationship between cytokines and pain/depression: a review and current status |
Q35933279 | The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation |
Q48197236 | The role of brain cytokines in mediating the behavioral and neuroendocrine effects of intracerebral mycoplasma fermentans. |
Q45758370 | The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). |
Q40385577 | The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression |
Q47966675 | The role of the vagus nerve in cytokine-to-brain communication |
Q37925849 | The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know |
Q40653399 | The two phases of biphasic fever--two different strategies for fighting infection? |
Q24648146 | The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFalpha-induced sickness behavior |
Q43742981 | Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha |
Q35590698 | Two-step synthesis of galactosylated human serum albumin as a targeted optical imaging agent for peritoneal carcinomatosis |
Q34171362 | Understanding cytokines. Part I: Physiology and mechanism of action |
Q36364203 | Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression |
Q34433036 | Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication |
Q41712834 | Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. |
Q48190539 | Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment |
Q48473361 | Vertebrate sickness behaviors: Adaptive and integrated neuroendocrine immune responses |
Q28611054 | Why Do We Feel Sick When Infected--Can Altruism Play a Role? |
Q88917772 | Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation |
Q35182043 | Zinc prevents sickness behavior induced by lipopolysaccharides after a stress challenge in rats. |
Q52679999 | [Hypothalamic inflammation and energy balance deregulations: focus on chemokines.] |
Search more.